A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma.

  title={A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma.},
  author={Sosuke Adachi and Tomohiko Ogasawara and Naruhiro Yamasaki and Hiroaki Shibahara and Ri-ichiro Kanazawa and Yasushi Tsuji and Takafumi Takemura and Kaori Murase Tetsuro Ogi Kota Saito Takahide Koyama},
  journal={Japanese journal of clinical oncology},
  volume={29 9},
BACKGROUND Ovarian clear cell adenocarcinoma is known to have poorer prognosis than ovarian serous cystadenocarcinoma. Cyclophosphamide plus cisplatin has been the standard therapy for ovarian cancer, but ovarian clear cell adenocarcinoma dose not respond to this therapy. The treatment for ovarian clear cell adenocarcinoma has not been established. We planned a pilot study of CPT-11 and cisplatin for the treatment of ovarian clear cell adenocarcinoma. METHODS First, three patients were… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 15 extracted citations

Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?

Journal of experimental & clinical cancer research : CR • 2012
View 1 Excerpt

The activity of trabectedin as a single agent or in combination with everolimus for clear cell carcinoma of the ovary.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2011

Similar Papers

Loading similar papers…